Search
Close this search box.
Search
Subscriber Log In
Commercial Opportunity Assessment

Evaluate for Commercial Opportunity Assessment

When bringing new assets into your pipeline, you need a deep understanding of their potential clinical and commercial differentiation, their competitive landscape, and the overall dynamics of the market they’re in. Access the breadth and depth of insights you need to prioritise opportunities and amplify commercial success. We combine company financials and profiles, product attributes, consensus forecasts, and market knowledge to help you take the right products to the right market in the right way.

Use Evaluate to access the breadth and depth of insights you need to prioritise opportunities and amplify commercial success. We combine company financials and profiles, product attributes, consensus forecasts, and market knowledge to help you take the right products to the right market in the right way.

Talk to us about your commercial opportunity assessment solutions

Focus on opportunities that align with your strategy

Don’t disappear down the rabbit hole of something that catches your eye. Be rigorous in your research and focus on the assets – internal or external – that best fit your long-term strategy. Assess the market to define a shortlist of key opportunities for your therapy area or indication.

Produce bottom-up forecasts for key assets

It’s vital that you can accurately assess the net present value and market potential of the assets you’re focused on. Adding industry-standard data to the valuation process provides confidence when making recommendations.

Build a highly detailed, accurate business case

Develop a well-validated forecast for in-licencing candidates using solid epidemiology data, pricing assumptions, prescribing patterns, and potential time to market. Ensure you model multiple scenarios so you fully understand the implications of potential market changes beyond your control.

How our solutions support commercial opportunity assessment

Evaluate Pharma

Identify growth-driving products, assess limitations and opportunities in the market, set up alerts for a timely view of the competitive landscape, utilise consensus forecasts for target products and technologies, contribute to business case development, and gain insights on market competitiveness.

Evaluate Omnium

Monitor competitors by tracking phase transition launches, key trials, and commercial events on specific portfolios, gaining insights into upcoming launch dates, success rates, and industry benchmarks. Value competitor assets and portfolios and conduct detailed competitive assessments to identify threats and market competitors based on development risk.

Evaluate Epi

Define the potential size of the patient population, tailor assets to the correct patient population, conduct in-depth asset valuations, and build patient-based forecasts.

Explore Another Use Case

Related Resources

Understand the context with data-driven insights